Pharmafile Logo

dual tasking

- PMLiVE

GlaxoSmithKline agrees $2.2bn dementia mAb deal with Alector

The focus of the deal is two clinical-stage monoclonal antibodies in development for a number of neurodegenerative diseases

- PMLiVE

The Spirit of Lucid Group

Since 2017, Lucid Group’s charity working group, LUCID SPIRIT, has been actively involved in helping to raise awareness and funds for its charity partners. At launch, Lucid Spirit partnered with the...

Lucid Group Communications Limited

- PMLiVE

Nestlé and Seres announce new partnership for C.diff microbiome therapeutic

The companies will jointly commercialise Seres’ investigational oral microbiome therapeutic in the US and Canada

- PMLiVE

J&J’s COVID-19 vaccine shows ‘strong’ activity against Delta variant

Vaccine produces durable immune responses lasting up to eight months

- PMLiVE

COVID-19 booster dose programme planned for September launch in Britain

The programme will be conducted in two stages for a range of priority groups

- PMLiVE

The importance of the human touch

by  Kirstie Turner

- PMLiVE

Elliott Management puts pressure on GSK after years of ‘disappointing performance’

Hedge fund has published a 17-page letter outlining recommendations following GSK's investor day last week

- PMLiVE

COUCH Health taps Mark Duman for chief strategy officer role

Duman has over 30 years of experience working in the healthcare sector

- PMLiVE

Ashfield Engage appoints Serap Becker as head of patient solutions in DACH region

Prior to joining Ashfield Engage, Becker served as director of direct to patient services at Marken

Open-Data Platforms for Direct Engagement with Patients, Researchers, and Pharma

Indu Navar, CEO and Founder of EverythingALS, explores the roles of Artificial Intelligence, Machine Learning, and Brain Computer Interface in the search for a cure for ALS. She will also...

Impetus Digital

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links